Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
219.72
+0.80 (0.37%)
May 8, 2024, 4:00 PM EDT - Market closed
Biogen Stock Forecast
Stock Price Forecast
The 24 analysts with 12-month price forecasts for Biogen stock have an average target of 291.38, with a low estimate of 200 and a high estimate of 373. The average target predicts an increase of 32.61% from the current stock price of 219.72.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock from 24 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 9 | 9 | 8 |
| Buy | 12 | 12 | 10 | 10 | 9 | 9 |
| Hold | 4 | 5 | 6 | 6 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 26 | 26 | 25 | 25 | 25 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Strong Buy Maintains $339 → $342 | Strong Buy | Maintains | $339 → $342 | +55.65% | May 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $270 | Buy | Maintains | $270 | +22.88% | Apr 29, 2024 |
| Barclays | Barclays | Hold Maintains $215 → $200 | Hold | Maintains | $215 → $200 | -8.98% | Apr 25, 2024 |
| Wedbush | Wedbush | Hold Maintains $213 → $215 | Hold | Maintains | $213 → $215 | -2.15% | Apr 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $325 → $300 | Strong Buy | Maintains | $325 → $300 | +36.54% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
9.64B
from 9.84B
Decreased by -1.95%
Revenue Next Year
9.78B
from 9.64B
Increased by 1.36%
EPS This Year
15.76
from 7.97
Increased by 97.75%
EPS Next Year
17.98
from 15.76
Increased by 14.09%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.2B | 12.0B | 13.1B | 13.4B | 14.6B |
| Avg | 9.6B | 9.8B | 10.3B | 10.9B | 11.3B |
| Low | 8.8B | 8.3B | 8.6B | 8.2B | 7.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.2% | 24.7% | 33.8% | 30.0% | 33.5% |
| Avg | -1.9% | 1.4% | 5.4% | 5.9% | 3.1% |
| Low | -10.5% | -14.4% | -12.5% | -20.6% | -28.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 16.89 | 22.46 | 28.83 | 28.75 | 30.71 |
| Avg | 15.76 | 17.98 | 20.30 | 22.72 | 23.44 |
| Low | 14.53 | 12.08 | 12.36 | 16.14 | 16.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 111.9% | 42.5% | 60.3% | 41.6% | 35.1% |
| Avg | 97.8% | 14.1% | 12.9% | 11.9% | 3.1% |
| Low | 82.4% | -23.3% | -31.3% | -20.5% | -29.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.